BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2256742)

  • 1. Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.
    Tolosa-Vilella C; Ordi-Ros J; Vilardell-Tarres M; Selva-O'Callaghan A; Jordana-Comajuncosa R
    Ann Rheum Dis; 1990 Nov; 49(11):935-6. PubMed ID: 2256742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cardiolipin antibodies, Raynaud's phenomenon with digital ischemia, and non small cell carcinoma of the lung.
    Vaidya S; Logan JW
    Scand J Rheumatol; 2001; 30(3):172-4. PubMed ID: 11469530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Raynaud's phenomenon in a patient with antinuclear antibody-negative systemic lupus erythematosus.
    Maxwell CJ; Potter E; Townsend J
    J Natl Med Assoc; 1988 May; 80(5):594-5. PubMed ID: 3262169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon.
    Lally EV
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Minimal etiological evaluation of Raynaud's phenomenon. 102 cases].
    Priollet P; Yeni P; Vayssairat M; Segond P; Tallon F; Housset E
    Presse Med; 1985 Nov; 14(39):1999-2003. PubMed ID: 2933722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pheochromocytoma associated with Jaccoud's-type arthropathy, Raynaud's phenomenon, positive antinuclear antibody and rheumatoid factor.
    Tsai JJ; Tsai WJ; Yen JH; Chen JR; Lin SF; Liu HW
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Sep; 10(9):518-21. PubMed ID: 7983696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction.
    Dinerman H; Goldenberg DL; Felson DT
    J Rheumatol; 1986 Apr; 13(2):368-73. PubMed ID: 3487650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma.
    Kohli M; Bennett RM
    J Rheumatol; 1995 Jul; 22(7):1393-4. PubMed ID: 7562782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute polyarthritis, pulmonary fibrosis and Raynaud's phenomenon disclosing polymyositis with anti-JO-1 antibody associated with Gougerot-Sjögren syndrome].
    Cardon T; Deprez X; Flipo RM; Hautefeuille P; Duquesnoy B; Delcambre B
    Rev Med Interne; 1993; 14(7):744-5. PubMed ID: 8191085
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 17. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diversity of Raynaud's phenomenon in childhood: report of six cases.
    Buoncompagni A; Scribanis R; Picco P; Di Rocco M; Gandullia P; Baldi L; Pistoia V
    Lupus; 1993 Jun; 2(3):183-6. PubMed ID: 8369809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Raynaud's disease with uterine cancer producing interleukin-6.
    Murashima A; Takasaki Y; Hashimoto H; Hirano T; Hirose S
    Clin Rheumatol; 1992 Sep; 11(3):410-2. PubMed ID: 1458793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.